美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
SERENTIL	016774	001	NDA	MESORIDAZINE BESYLATE	TABLET;ORAL	EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	1970/02/27	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERENTIL	016774	002	NDA	MESORIDAZINE BESYLATE	TABLET;ORAL	EQ 25MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	1970/02/27	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERENTIL	016774	003	NDA	MESORIDAZINE BESYLATE	TABLET;ORAL	EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	1970/02/27	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERENTIL	016774	004	NDA	MESORIDAZINE BESYLATE	TABLET;ORAL	EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	1970/02/27	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERENTIL	016775	001	NDA	MESORIDAZINE BESYLATE	INJECTABLE;INJECTION	EQ 25MG BASE/ML	No	No	1970/02/27	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERENTIL	016997	001	NDA	MESORIDAZINE BESYLATE	CONCENTRATE;ORAL	EQ 25MG BASE/ML	No	No	1972/01/31	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued